Here are relevant reports on : contract-manufacturing-organization-market
-
Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021
The global downstream processing market is projected to grow at a CAGR of 16.4%. In this report, the global downstream processing market is broadly segmented on the basis of technique, product, application, end user, and region.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Services Market - Global Forecast to 2024
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Orthopedic, Dental), Class of Device (Class I, II, III), Service (Device Development & Manufacturing, Packaging & Assembly, Quality Management) - Global Forecast to 2030
The global medical device contract manufacturing market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Medical Device Manufacturing Equipment (by Production) Market by Type (Material Processing, Sterilization & Cleaning Equipment), Application (Consumables & Disposables), End User (OEMs, Contract Manufacturing Organizations) - Global Forecast to 2030
The global medical device manufacturing equipment (by production) market, valued at US$18.0 billion in 2024, stood at US$19.24 billion in 2025 and is projected to advance at a resilient CAGR of 7.0% from 2025 to 2030, culminating in a forecasted valuation of US$27.80 billion by the end of the period. The medical device manufacturing equipment (by production) market is driven by advancements in automation, robotics, and precision machining, along with increasing demand for high-quality, regulatory-compliant devices.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
FinTech Blockchain Market by Provider, Application (Payments, Clearing, and Settlement, Exchanges and Remittance, Smart Contract, Identity Management, and Compliance Management/KYC), Organization Size, Vertical, and Region - Global Forecast to 2023
The FinTech blockchain market is expected to grow from USD 370.3 Million in 2018 to USD 6,228.2 Million by 2023, at a Compound Annual Growth Rate (CAGR) of 75.9% during the forecast period. The major drivers of the FinTech blockchain market include the higher compatibility with financial industry ecosystem, the rising crypto-currency market cap and Initial Coin Offering (ICO), faster transaction, and reduced total cost of ownership. The future growth opportunities for FinTech blockchain market include the rising adoption of blockchain applications, such as payments, clearing, and settlements, smart contracts, and identity management, and a new breed of programmable blockchain platform. The major FinTech blockchain technology vendors include AWS (US), IBM (US), Microsoft (US), Ripple (US), Chain (US), Earthport (UK), Bitfury (US), BTL Group (Canada), Oracle (US), Digital Asset Holdings (US), Circle (Ireland), Factom (US), AlphaPoint (US), Coinbase (US), Abra (US), Auxesis Group (India), BitPay (US), BlockCypher (US), Applied Blockchain (UK), RecordesKeeper (Spain), Symbiont (US), Guardtime (Estonia), Cambridge Blockchain (US), Tradle (US), and Blockchain Advisory Mauritius Foundation (Mauritius).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023
The major players operating in the global protein binding assay market are Thermo Fisher (US), HTDialysis (US), Merck (US), GE Healthcare (US), and Absorption Systems (US). The global protein binding market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at a CAGR of 10.7%. The growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving the growth of this market. The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
